Rallybio RLYB
NASDAQ RLYB
$16.32 -0.06 (-0.40%)
As of: Oct 21, 2026 · 3:59 PM EDT

Rallybio (RLYB) Tax Rate (2026)

Updated

Rallybio's Tax Rate was 2.94% in Q2 2026.

Analysis

Rallybio (RLYB) Tax Rate (2026) Analysis & Trends

On a trailing twelve-month basis, Rallybio's Tax Rate was 2.82% through Jun 30, 2026; for FY2020, it was 0.06%.

  • The Q2 2026 figure marks the lowest quarterly Tax Rate since Q4 2020.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Tax Rate (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 23.27%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 17.98%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 15.47%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 23.71%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 10.40%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 14.20%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Rallybio 92.10 Mn -161.60 Mn - 2.94%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.94%
API Access

Rallybio Tax Rate API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=tax-rate&ticker=RLYB&period=max&api_key=YOUR_API_KEY